Who
Richard Peter Marshall
Director
Company insider
Files Form 4 as: Director, Serina Therapeutics.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 0
- Bought
- $40K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Apr 2024
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,250 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,250 at $0.00 | filing |
| 19 May 2026filed 22 May 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Bought | $20K12,183 at $1.65 | filing |
| 19 May 2026filed 22 May 2026 | SER Serina TherapeuticsBiotechnology | SEC FORM 4 Bought | $20K12,183 at $1.65 | filing |
| 7 Nov 2025filed 10 Nov 2025 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
Serina Therapeutics, Inc. (NYSEAMERICAN:SER) Stock Short Interest Report for SeptemberSER · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Richard Peter Marshall; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.